The mechanisms, by which TRA inhibits Her2-overexpressing cancer cells growth, are not completely defined, but down-modulation of PI3K/Akt and/or Ras/MAPK signaling pathways are essential features of TRA response leading to eventual cell cycle arrest (9). Here, ERBB2 is linked to cancer.